Conavi Medical Corp. (CNVIF)

OTCMKTS · Delayed Price · Currency is USD
0.3650
0.00 (0.00%)
Mar 31, 2025, 4:00 PM EST
608.74%
Market Cap 18.16M
Revenue (ttm) 1.60M
Net Income (ttm) -32.28M
Shares Out n/a
EPS (ttm) -5.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2
Average Volume 4,391
Open 0.3650
Previous Close 0.3650
Day's Range 0.3650 - 0.3650
52-Week Range 0.0007 - 1.0000
Beta n/a
RSI 45.30
Earnings Date Mar 7, 2025

About Conavi Medical

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada. [Read more]

Industry Medical Devices
Sector Healthcare
CEO Thomas Looby
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol CNVIF
Full Company Profile

Financial Performance

In 2024, Conavi Medical's revenue was 2.16 million, a decrease of -8.59% compared to the previous year's 2.36 million. Losses were -43.62 million, 67.2% more than in 2023.

Financial numbers in CAD Financial Statements

News

Conavi Medical Corp. Announces Upsize to its Previously Announced Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 21, 2025 (GLOBE NEWSWIRE) --  Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “C...

11 days ago - GlobeNewsWire

Conavi Medical Announces Uplisting to OTCQB Venture Market

-  E xpected to enhance visibility and access to U.S. investors

26 days ago - GlobeNewsWire

Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines

– IVUS and OCT cited as playing essential and complementary roles, validating Novasight's unique hybrid imaging capability – Guidelines constitute strong recommendations based on the highest level of ...

4 weeks ago - GlobeNewsWire

Conavi Medical Retains BND Projects Inc. for Corporate Development Services

TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Corporation”), a commercial stage medical device company focused on designing, manufacturing, and marketi...

2 months ago - GlobeNewsWire

Conavi Medical Corp. Announces Proposed Public Offering of Units

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi M...

2 months ago - GlobeNewsWire